Choroidal naevus regression associated with PD-1 inhibitor monotherapy for metastatic cutaneous malignant melanoma

被引：2
|
作者：
Krohn, Jorgen [1 ,2 ]
Hanken, Geir [3 ]
Herlofsen, Oluf [4 ]
机构：
[1] Univ Bergen, Dept Clin Med, Sect Ophthalmol, Bergen, Norway
[2] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway
[3] More & Romsdal Hosp Trust, Alesund Hosp, Dept Ophthalmol, Alesund, Norway
[4] More & Romsdal Hosp Trust, Alesund Hosp, Dept Oncol, Alesund, Norway
来源：
ACTA OPHTHALMOLOGICA | 2020年 / 98卷 / 02期
关键词：
D O I：
10.1111/aos.14237
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E262 / E264
页数：3
相关论文
共 50 条
  • [1] Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
    Arko, Rozala
    Boc, Nina
    Boc, Marko
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2022, 4
  • [2] Metastatic malignant Melanoma with an unknown Primary, long-term Remission by PD-1 Monotherapy with extended Administration Interval
    Hildebrandt, L.
    Koester, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 30 - 30
  • [3] Cutaneous Metastatic Melanoma Resembling a Halo Nevus, in the Setting of PD-1 Inhibition
    Harvey, Nathan Tobias
    Millward, Michael
    Macgregor, Kirstie
    Bucat, Robert Paul
    Wood, Benjamin Andrew
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2016, 38 (12) : E159 - E162
  • [4] PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis
    Lin, Zhijuan
    Chen, Xing
    Li, Zhifeng
    Luo, Yiming
    Fang, Zhihong
    Xu, Bing
    Han, Mingzhe
    PLOS ONE, 2016, 11 (08):
  • [5] PD-1 Inhibitor Approved for Melanoma
    不详
    CANCER DISCOVERY, 2014, 4 (11) : 1249 - 1249
  • [6] Successful Treatment of Metastatic Primary Cutaneous Adnexal Carcinoma With a PD-1 Inhibitor
    Patel, Janmesh D.
    Pozorski, Vincent J.
    Tavberidze, Nika
    Buehler, Darya G.
    Huang, Wei
    Bennett, Daniel D.
    Ma, Vincent T.
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (08) : 323 - 327
  • [7] Real-world data on PD-1 inhibitor therapy in metastatic melanoma
    Arheden, Anna
    Skalenius, Joanna
    Bjursten, Sara
    Stierner, Ulrika
    Ny, Lars
    Levin, Max
    Jespersen, Henrik
    ACTA ONCOLOGICA, 2019, 58 (07) : 962 - 966
  • [8] Beyond PD-1 Immunotherapy in Malignant Melanoma
    Dominika Kwiatkowska
    Piotr Kluska
    Adam Reich
    Dermatology and Therapy, 2019, 9 : 243 - 257
  • [9] Beyond PD-1 Immunotherapy in Malignant Melanoma
    Kwiatkowska, Dominika
    Kluska, Piotr
    Reich, Adam
    DERMATOLOGY AND THERAPY, 2019, 9 (02) : 243 - 257
  • [10] Clinical presentation of immune-related colitis associated with PD-1 inhibitor monotherapy (MONO) and combination PD-1/CTLA-4 inhibitors (COMBO) in melanoma.
    Wang, Daniel Ying
    Kim, Dae Won
    Shah, Neil J.
    Conry, Robert Martin
    Mehta, Rutika Jitesh
    Silk, Ann W.
    Zhou, Alice
    Voorhees, Amber L.
    Mckee, Svetlana B.
    Norrell, Jacqueline
    Mehnert, Janice M.
    Puzanov, Igor
    Gibney, Geoffrey Thomas
    Rapisuwon, Suthee
    Eroglu, Zeynep
    Johnson, Douglas Buckner
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345